Citius Pharmaceuticals CTXR shares tumbled on Friday after the company announced a registered direct offering, a financing ...

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) announced it has entered into a definitive agreement to raise approximately $5 ...

Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, ...

Citius Pharmaceuticals has been making big preparations as it gears up for the commercialization of its two late-stage products, including realigning its management team. On May 25, the Cranford-based ...

Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.

Update: Citius Pharmaceuticals announced Aug. 5, 2024, that TenX Keane Acquisition’s shareholders approved their previously announced merger, which is expected to close “in the coming weeks.” Read ...

This press release and the interview to which it relates may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities ...

Citius TransNet Investment Trust is a transport-focused infrastructure investment trust set up to acquire, manage and invest ...

Discover if Citius TransNet InvIT IPO is a worthwhile investment with insights on its financials and growth potential.